查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
DTC (Direct-to-Consumer) 基因檢測：全球市場與各種技術
市場調查報告書
商品編碼
1590311

DTC (Direct-to-Consumer) 基因檢測：全球市場與各種技術

Direct-to-Consumer Genetic Testing: Global Markets and Technologies
出版日期: | 出版商: BCC Research | 英文 84 Pages | 訂單完成後即時交付

價格

全球 DTC（Direct-to-Consumer）基因檢測市場預計將從2024年的23億美元成長到2029年終的37億美元，預測期內年複合成長率為 10.0%。

血統檢測產業預計將從2024年的16億美元成長到2029年終的24億美元，年複合成長率為 9.2%。此外，健康檢測產業預計將從2024年的5.168億美元成長到2029年終的9.484億美元，年複合成長率為 12.9%。

本報告調查了全球 DTC（Direct-to-Consumer）基因檢測市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢以及市場規模趨勢 - 詳細編制了預測。品類、地區分析、競爭狀況、主要企業概況等

目錄

第1章 執行摘要

  • 市場展望
  • 調查範圍
  • 市場概況

第2章 市場概況

  • 市場概況與定義
  • 基因檢測
  • DTC基因檢測的歷史
  • DTC 基因檢測的類型
  • 法律規範
  • 美國
  • 歐洲
  • 亞太地區

第3章 市場動態

  • 市場動態
  • 市場促進因素
  • 降低基因組定序成本
  • 積極的行銷
  • 藥物基因組測試
  • 慢性病增加
  • 提高認知
  • 市場機會
  • 加強患者與醫師之間的合作
  • 市場限制因素
  • DTC基因檢測效率低下
  • 保險範圍有限
  • 隱私問題
  • 錯誤的結果
  • 增加推薦的成本
  • 市場挑戰
  • 供應鏈挑戰
  • 資料管理、品管、客戶服務

第4章 新興科技與發展

  • 概述
  • AI
  • 全基因組定序和全基因組定序
  • 區塊鏈技術
  • 藥物開發中的基因組資料

第5章 DTC基因檢測市場

  • 細分細分
  • 市場區隔：依產品類型
  • Ancestry DTC基因檢測市場
  • 健康狀況DTC基因檢測市場
  • 生活型態DTC基因檢測市場
  • 地域分佈
  • 市場區隔：依地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 其他領域

第6章 競爭訊息

  • 產業場景
  • 企業市場占有率
  • 競爭格局

第7章 DTC基因檢測產業的永續性：ESG視角

  • ESG：簡介
  • 環境績效
  • 社會表現
  • 管治績效
  • BCC的結語

第8章 專利分析

第9章 附錄

  • 調查方法
  • 參考
  • 簡稱
  • 公司簡介
  • 23ANDME INC.
  • ANCESTRY
  • COLOR HEALTH INC.
  • DANTE LABS GLOBAL
  • MYDNA LIFE AUSTRALIA PTY LTD.
  • MYHERITAGE LTD.
  • PRIVAPATH DIAGNOSTICS
Product Code: MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

The ancestry segment of DTC genetic testing market is expected to grow from $1.6 billion in 2024 and is projected to reach $2.4 billion by the end of 2029, at a CAGR of 9.2% during the forecast period of 2024 to 2029.

The health segment of DTC genetic testing market is expected to grow from $516.8 million in 2024 and is projected to reach $948.4 million by the end of 2029, at a CAGR of 12.9% during the forecast period of 2024 to 2029.

Report scope

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies' revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle. The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and others). The lifestyle market segment is segmented by technology and application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness and others).

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

In this report, the market is divided into the following segments:

Market applications:

  • Ancestry.
  • Health.
  • Lifestyle.

Technologies:

  • Genotyping arrays.
  • Whole genome sequencing (WGS).
  • Whole exome sequencing (WES).
  • Polymerase chain reaction (PCR).
  • Targeted sequencing.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

Report Includes

  • 18 data tables and 27 additional tables
  • An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
  • Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
  • Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
  • Profiles of the major players, including Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Market Overview and Definitions
  • Genetic Testing
  • History of DTC Genetic Testing
  • Types of DTC Genetic Tests
  • Regulatory Framework
  • United States
  • Europe
  • Asia-Pacific

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Dropping Cost of Genomic Sequencing
  • Aggressive Marketing
  • Pharmacogenomic Testing
  • Increasing Prevalence of Chronic Diseases
  • Increasing Awareness
  • Market Opportunities
  • Enhancing Patient-Physician Collaboration
  • Market Restraints
  • Inefficiencies of DTC Genetic Tests
  • Limited Insurance Coverage
  • Privacy Concerns
  • False Results
  • Costs of Increased Referrals
  • Market Challenges
  • Supply Chain Challenges
  • Data Management, Quality Control and Customer Service

Chapter 4 Emerging Technologies and Developments

  • Overview
  • Artificial Intelligence
  • WGS and WES
  • Blockchain Technology
  • Genomic Data in Drug Development

Chapter 5 DTC Genetic Testing Market

  • Segmentation Breakdown
  • Market Breakdown, by Product Type
  • Ancestry DTC Genetic Testing Market
  • Health DTC Genetic Testing Market
  • Lifestyle DTC Genetic Testing Market
  • Geographic Breakdown
  • Market Breakdown, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Industry Scenario
  • Company Shares
  • Competitive Landscape

Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective

  • Introduction to ESG
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC

Chapter 8 Patent Analysis

Chapter 9 Appendix

  • Research Methodology
  • References
  • Abbreviations
  • Company Profiles
  • 23ANDME INC.
  • ANCESTRY
  • COLOR HEALTH INC.
  • DANTE LABS GLOBAL
  • MYDNA LIFE AUSTRALIA PTY LTD.
  • MYHERITAGE LTD.
  • PRIVAPATH DIAGNOSTICS

List of Tables

  • Summary Table : Global DTC Genetic Testing Market, by Product Type, Through 2029
  • Table 1 : DTC Genetic Testing Types
  • Table 2 : Products from Selected DTC Genetic Testing Companies
  • Table 3 : DTC Genetic Testing Synonyms
  • Table 4 : FDA Regulatory Pathways for DTC Genetic Testing
  • Table 5 : DTC Genetic Tests with FDA Marketing Authorization
  • Table 6 : Cases of Diabetes, by Country, 2021
  • Table 7 : Global Incidence of All Cancers, by Region, Estimated and Projected, 2022-2045
  • Table 8 : Global DTC Genetic Testing Market, by Product Type, Through 2029
  • Table 9 : Global DTC Genetic Testing Market, by Technology, Through 2029
  • Table 10 : Global DTC Genetic Testing Market, by Delivery Format, Through 2029
  • Table 11 : Global Ancestry DTC Genetic Testing Market, by Technology, Through 2029
  • Table 12 : Global Health DTC Genetic Testing Market, by Disease Category, Through 2029
  • Table 13 : Global Health DTC Genetic Testing Market, by Technology, Through 2029
  • Table 14 : Global Lifestyle DTC Genetic Testing Market, by Application, Through 2029
  • Table 15 : Global Lifestyle DTC Genetic Testing Market, by Technology, Through 2029
  • Table 16 : Global DTC Genetic Testing Market, by Region, Through 2029
  • Table 17 : North American DTC Genetic Testing Market, by Country, Through 2029
  • Table 18 : European DTC Genetic Testing Market, by Country, Through 2029
  • Table 19 : Asia-Pacific DTC Genetic Testing Market, by Country, Through 2029
  • Table 20 : Latin American DTC Genetic Testing Market, by Country, Through 2029
  • Table 21 : RoW DTC Genetic Testing Market, Through 2029
  • Table 22 : ESG: Environmental Overview
  • Table 23 : ESG: Social Overview
  • Table 24 : ESG: Governance Overview
  • Table 25 : Patents Related to DTC Genetic Testing, January 2020 to September 2024
  • Table 26 : Abbreviations Used in This Report
  • Table 27 : 23andMe Inc.: Company Snapshot
  • Table 28 : 23andMe Inc.: Financial Performance, 2022 and 2023
  • Table 29 : 23andMe Inc.: Product Portfolio
  • Table 30 : 23andMe Inc.: News/Key Developments, 2023
  • Table 31 : Ancestry: Company Snapshot
  • Table 32 : Ancestry: Product Portfolio
  • Table 33 : Color Health Inc.: Company Snapshot
  • Table 34 : Color Health Inc.: Product Portfolio
  • Table 35 : Color Health Inc.: News/Key Developments, 2024
  • Table 36 : Dante Labs Global: Company Snapshot
  • Table 37 : Dante Labs Global: Product Portfolio
  • Table 38 : Dante Labs Global: News/Key Developments, 2023 and 2021
  • Table 39 : myDNA Life Australia Pty Ltd.: Company Snapshot
  • Table 40 : myDNA Life Australia Pty Ltd.: Product Portfolio
  • Table 41 : MyHeritage Ltd.: Company Snapshot
  • Table 42 : MyHeritage Ltd.: Product Portfolio
  • Table 43 : PrivaPath Diagnostics: Company Snapshot
  • Table 44 : PrivaPath Diagnostics: Product Portfolio

List of Figures

  • Summary Figure A : Global DTC Genetic Testing Market, by Product Type, 2021-2029
  • Summary Figure B : Global DTC Genetic Testing Market Shares, by Product Type, 2023
  • Figure 1 : Developments in DTC Genetic Testing Since the 1990s
  • Figure 2 : DTC Genetic Testing: Market Dynamics
  • Figure 3 : Share of All Cancer Cases Globally, by Region, 2022
  • Figure 4 : Emerging Technologies in DTC Genetic Testing
  • Figure 5 : Global DTC Genetic Testing Market Shares, by Product Type, 2023
  • Figure 6 : Global DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 7 : Global DTC Genetic Testing Market Shares, by Delivery Format, 2023
  • Figure 8 : Global Ancestry DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 9 : Global Health DTC Genetic Testing Market Shares, by Disease Category, 2023
  • Figure 10 : Global Health DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 11 : Global Lifestyle DTC Genetic Testing Market Shares, by Application, 2023
  • Figure 12 : Global Lifestyle DTC Genetic Testing Market Shares, by Technology, 2023
  • Figure 13 : Global DTC Genetic Testing Market Shares, by Region, 2023
  • Figure 14 : North American DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 15 : European DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 16 : Asia-Pacific DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 17 : Latin American DTC Genetic Testing Market Shares, by Country, 2023
  • Figure 18 : Global Company Shares of DTC Genetic Testing Market, 2023
  • Figure 19 : ESG Pillars
  • Figure 20 : Advantages of ESG for Companies
  • Figure 21 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023
  • Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023